Pervaiz Iqbal, MD
NPI 1083658918ActiveIndividual· Internal Medicine, Pulmonary Disease· South Richmond Hill, NY
Internal Medicine, Pulmonary Disease (MD) in South Richmond Hill, New York, licensed in NY, with an NPI issued in June 2006. Their prescriptions cost Medicare Part D more than their services did: $1,616,156 for 7,696 claims, against $220,669 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 7 companies reporting payments in 2025, $1,208 in all, mostly food and beverage.
Overview
| NPI | 1083658918 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jun 14, 2006 |
| Last updated in NPPES | Nov 13, 2024 |
| Certified by provider | Nov 13, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 230198 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Internal Medicine (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 253 |
|---|---|
| Services billed | 11,554 across 45 procedure codes |
| Paid by Medicare | $220,669 |
Part D prescriptions in 2024
| Prescriptions (claims) | 7,696 · 12,599 30-day fills |
|---|---|
| Patients | 685 |
| Total drug cost | $1,616,156 |
| Generic share | 71% of claims |
Education and affiliations
| Graduation year | 1982 |
|---|---|
| Medicare specialty | Internal Medicine |
| Secondary specialties | Pulmonary Disease |
| Telehealth | Offers telehealth |
Industry payments (Open Payments)
- 2025$1,208 · 51 payments from 7 companies
- 2024$978.80 · 32 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $592.97 | 26 |
| Glaxosmithkline, LLC. | $339.33 | 13 |
| Phathom Pharmaceuticals, Inc. | $125.60 | 6 |
| Exact Sciences Corporation | $80.14 | 3 |
| Genzyme Corporation | $29.90 | 1 |
What the 2025 payments were for
- Food and Beverage$1,208 · 51 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records